127 related articles for article (PubMed ID: 17852444)
21. Acute seizures due to a probable interaction between valproic acid and meropenem.
Coves-Orts FJ; Borrás-Blasco J; Navarro-Ruiz A; Murcia-López A; Palacios-Ortega F
Ann Pharmacother; 2005 Mar; 39(3):533-7. PubMed ID: 15701769
[TBL] [Abstract][Full Text] [Related]
22. Pathological case of the month: sudden death in a child as a result of pancreatitis during valproic acid therapy.
Mileusnic D; Donoghue ER; Lifschultz BD
Pediatr Pathol Mol Med; 2002; 21(5):477-84. PubMed ID: 12396903
[TBL] [Abstract][Full Text] [Related]
23. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
24. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q).
Kanagal-Shamanna R; Yin CC; Miranda RN; Bueso-Ramos CE; Wang XI; Muddasani R; Medeiros LJ; Lu G
Cancer Genet; 2013; 206(1-2):42-6. PubMed ID: 23357231
[TBL] [Abstract][Full Text] [Related]
25. Isochromosome 1q in a myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
Pawarode A; Finlay E; Sait SN; Barcos M; Baer MR
Cancer Genet Cytogenet; 2006 Jun; 167(2):155-60. PubMed ID: 16737916
[TBL] [Abstract][Full Text] [Related]
26. Valproic acid and all-trans retinoic acid: meta-analysis of a palliative treatment regimen in AML and MDS patients.
Bellos F; Mahlknecht U
Onkologie; 2008 Nov; 31(11):629-33. PubMed ID: 19145098
[TBL] [Abstract][Full Text] [Related]
27. Azathioprine: association with therapy-related myelodysplastic syndrome and acute myeloid leukemia.
Kwong YL
J Rheumatol; 2010 Mar; 37(3):485-90. PubMed ID: 20080917
[TBL] [Abstract][Full Text] [Related]
28. Valproic acid for the treatment of low-risk myelodysplastic syndromes: A case report and a review of the literature.
Poloni A; Costantini B; Mariani M; Leoni P
Leuk Res Rep; 2013; 2(2):44-6. PubMed ID: 24371778
[TBL] [Abstract][Full Text] [Related]
29. Valproic acid-induced eosinophilic pleural effusion: a case report and review of the literature.
Kamenetsky Z; Da'as N; Esayag Y; Kleinman Y; Samuels N
Neurologist; 2012 Jan; 18(1):39-40. PubMed ID: 22217614
[TBL] [Abstract][Full Text] [Related]
30. Adult-onset of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome presenting as acute meningoencephalitis: a case report.
Hsu YC; Yang FC; Perng CL; Tso AC; Wong LJ; Hsu CH
J Emerg Med; 2012 Sep; 43(3):e163-6. PubMed ID: 20036095
[TBL] [Abstract][Full Text] [Related]
31. Recurrent pancreatitis induced by valproic acid. A case report and review of the literature.
Parker PH; Helinek GL; Ghishan FK; Greene HL
Gastroenterology; 1981 Apr; 80(4):826-8. PubMed ID: 6162706
[TBL] [Abstract][Full Text] [Related]
32. Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir.
Sagot-Lerolle N; Lamine A; Chaix ML; Boufassa F; Aboulker JP; Costagliola D; Goujard C; Pallier C; Delfraissy JF; Lambotte O;
AIDS; 2008 Jun; 22(10):1125-9. PubMed ID: 18525257
[TBL] [Abstract][Full Text] [Related]
33. A rare occurrence of isolated neutropenia with valproic acid: a case report.
Chakraborty S; Chakraborty J; Mandal S; Ghosal MK
J Indian Med Assoc; 2011 May; 109(5):345-6. PubMed ID: 22187773
[TBL] [Abstract][Full Text] [Related]
34. Valproic acid and thrombocytopenia. Case report.
Patel CC; Church S; Reilly KM
J Ky Med Assoc; 1982 Apr; 80(4):213-5. PubMed ID: 6808068
[No Abstract] [Full Text] [Related]
35. [Acute Intermittent porphyria and valproic acid].
Noval Menéndez J; Campoamor MT; Laborda B; López-Colina G
Rev Clin Esp; 2012 Apr; 212(4):217-8. PubMed ID: 22112281
[No Abstract] [Full Text] [Related]
36. High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapy.
de Maat MM; van Leeuwen HJ; Edelbroek PM
Ann Pharmacother; 2011 Mar; 45(3):e18. PubMed ID: 21325101
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effect of bortezomib and valproic acid treatment on the proliferation and apoptosis of acute myeloid leukemia and myelodysplastic syndrome cells.
Wang AH; Wei L; Chen L; Zhao SQ; Wu WL; Shen ZX; Li JM
Ann Hematol; 2011 Aug; 90(8):917-31. PubMed ID: 21340723
[TBL] [Abstract][Full Text] [Related]
38. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome.
Arber C; Buser A; Heim D; Gratwohl A; Tichelli A; Passweg JR
Eur J Haematol; 2006 Mar; 76(3):255-7. PubMed ID: 16451398
[TBL] [Abstract][Full Text] [Related]
40. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
Mallet L; Babin S; Morais JA
Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
